LabStyle Innovations Corp (OTCMKTS:DRIO) Gains Some Ground

[[tagnumber 0]][[tagnumber 1]]LabStyle Innovations Corp (OTCMKTS:DRIO)’s stock was hovering around the 20 cent per share mark throughout the first quarter of the year and the daily volumes that it recorded through that period were very small.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]As March came to an end, however, [[tagnumber 6]]DRIO [[tagnumber 7]]filed its annual report which contained the very first revenues of the company. This pushed the price up and as more positive news came from company HQ we also saw the volumes increase. The ticker was headed for the 50 cent per share mark, but began to hesitate as it reached $0.45 on April 10.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]A quick descent followed and the general direction in which the stock was moving until the end of April was downward. As more positive news came in this month [[tagnumber 6]]DRIO [[tagnumber 7]]saw some green sessions. Yesterday the company managed to file its report for the first quarter of the year. It contained these numbers of prime interest.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 17]] [[tagnumber 18]]cash: $1.85 million[[tagnumber 19]] [[tagnumber 18]]current assets: $2.44 million[[tagnumber 19]] [[tagnumber 18]]current liabilities: $1.66 million[[tagnumber 19]] [[tagnumber 18]]quarterly revenues: $67 thousand[[tagnumber 19]] [[tagnumber 18]]quarterly net loss: $1.63 million[[tagnumber 19]] [[tagnumber 28]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]We see a small increase in revenues quarter–over–quarter and we also see that [[tagnumber 6]]DRIO [[tagnumber 7]]management has lowered the net loss. The cash positions of the company remain very decent, but the liabilities have barely moved.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The report was filed after the session ended so the 12.14% gain from yesterday isn’t a result of it. The press release concerning the Health Canada approval for commercialization of the Dario™ diabetes management solution is more likely the culprit behind the positive movement that left [[tagnumber 6]]DRIO [[tagnumber 7]]standing at $0.3925 in the end of the day.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]We are yet to see how the investor community is going to react to the quarterly report so be sure to do your due diligence and weigh out the risks before putting any money on the line.[[tagnumber 2]]